Hypercholesterolemia: Shared Decision-Making
Read More
Lifestyle Modifications to Manage Hypercholesterolemia
Cardiovascular Disease in Younger Populations
Socioeconomic Status and Hypercholesterolemia
Cardiovascular Disease Risk Factors
Consequences of Hypercholesterolemia
Closing Thoughts for the Management of CVD
Emerging Therapies for the Treatment of CVD
Treatment of CVD: Bempedoic Acid Monotherapy + Ezetimibe
CVD Real-World Case Scenario 3
CVD Real-World Case Scenario 2
CVD Real-World Case Scenario 1
Adverse Effects of PCSK9 Inhibitors in CVD
Add-On Therapy With Statins and PCSK9 Inhibitors in CVD
CVD: EVAPORATE Trial and COVID-19 Pilot Study
CVD: REDUCE-IT Trial
CVD Risk Reduction and Prevention
Prevalence of CVD Associated With Hypercholesterolemia
Overview of Cardiovascular Risks
Management of Rheumatic Diseases with Biologic Agents: Key Takeaways
Nonradiographic Axial Spondyloarthritis Patient Case Overview and Management of Reproductive Health
Rheumatoid Arthritis Patient Case Overview and Therapeutic Goals
Psoriatic Arthritis Patient Case Overview and Therapeutic Goals
Lifestyle Modifications for Patients to Adapt During COVID-19
Telehealth Strategies for Patients During COVID-19 Pandemic
Other Agents Used to Treat Cardiovascular Patients With COVID-19
Effects of IPE on Inflammatory Biomarkers in Patients With COVID-19
Treating Cardiovascular Risks in Patients Tested for COVID-19
Cardiac Biomarker Assessment for Patients With COVID-19
Reluctance in Getting Vaccinated to Prevent Coronavirus